Synthesis of Novel Quinazolin-4-one hybrids as potential antimicrobial agents

https://doi.org/10.53730/ijhs.v6nS2.6573

Authors

  • Yogesh Kumar Lawaniya Bhupal Noble's Institute of Pharmaceutical Sciences, Bhupal Nobles’, University, Udaipur -313001, India
  • Pradeep Kumar Goyal Bhupal Noble's Institute of Pharmaceutical Sciences, Bhupal Nobles’, University, Udaipur -313001, India

Keywords:

isoquinolines, N-acyl anthranilamides, potential antimicrobial

Abstract

We have developed an effortless and extremely efficient procedure for the synthesis of quinazolin-4-one derivatives via palladium-catalyzed C-Ccoupling of aryl amide with isocyanides. The reactions are operationally simple and avoid using toxic carbon monoxide and acid chloride, which must be used in an anhydrous system. The structure of the novel compounds was confirmed based on spectral data. We also demonstrated the biological potential of these compounds as novel Antifungal Activity. Based on the MIC results, the most active is 3g.

Downloads

Download data is not yet available.

References

Wang, Y-F; Toh, K. K; Lee, J-Y.; Chiba, S. Angew. Chem. Int. Ed. 2011, 50, 5927 (b) Tsukano, C.; Okuno, M.; Takemoto, Y. Angew. Chem. Int. Ed. 2012, 51, 1 (c) Fusano, A.; Fukuyama, T.; Nishitani, S.; Inouye, T.; Ryu, I. Org. Lett. 2010, 12, 2410, (d) Guimond, N.; Fagnou, K. J. Am. Chem. Soc. 2009, 131, 12050 (e) Okamoto, N.; Sakurai, K.; Ishikura, M.; Takeda, K.; Yanada, R. Tetrahedron Lett. 2009, 50, 4167 (f) Nandi, S.; Samanta, S.; Jana, S.; Ray, J. K. Tetrahedron Lett. 2010, 51, 5294 (g) Ouyang, H. C.; Tang, R-Y.; Zhong, P.; Zhang, X-G.; Li, J-H. J. Org. Chem. 2011, 76, 223 (h) Leibeling, M.; Pawliczek, M.; Kratzert, D.; Stalke, D.; Werz, D-B. Org. Lett. 2012, 14, 346.

(a) Ma, B.; Wang, Y.; Peng, J.; Zhu, Q. J. Org. Chem. 2011, 76, 6362 (b) Skoda-Foldes, R.; Kollar, L. Curr. Org. Chem. 2002, 6, 1097 (c) Wu, X-F.; Anbarasan, P.; Neumann, H.; Beller, M. Angew. Chem. Int. Ed. 2010, 49, 7316 (d) Houlden, C. E.; Hutchby, M.; Bailey, C. D.; Ford, J, G.; Tyler, S. N. G.; Gagné, M. R.; Lloyd-Jones, G. C.; Booker-Milburn, K-I.; Angew. Chem. Int. Ed. 2009, 48, 1830 (e) Giri, R.; Yu, J-Q, J. Am. Chem. Soc. 2008, 130, 14082 (f) Yoo, E-J.; Wasa, M.; Yu, J-Q. J. Am. Chem. Soc. 2010, 132, 17378 (g) Fusano, A.; Fukuyama, T.; Nishitani, S.; Inouye, T.; Ryu, I. Org. Lett., 2010, 12 2411 2410, (h) Kadnikov, D. V.; Larock, R. C. J. Org. Chem. 2004, 69, 6772 (i) Gimeno, A.; Medio-Simón, M.; Ramírez de Arellano, C.; Asensio, G.; Cuenca, A. B. Org. Lett. 2010, 12, 1900, (j) Saito, T.; Ogawa, S.; Takei, N.; Kutsumura, N.; Otani, T. Org. Lett., 2011, 13, 1098 (k) Yang, G.; Zhang, W. Org. Lett. 2012, 14, 268.

(a) Zhang, S.; Zhang, W.-X.; Xi, Z. Chem. Eur. J. 2010, 16, 8419 (b) Wang, Y.; Zhu, Q. Adv. Synth. Catal. 2012, 354, 1902 (c) Van Baelen, G.; Kuijer, S.; Rýček, L.; Sergeyev, S.; Janssen, E.; De Kanter, F. J. J.; Maes, B. U. W.; Ruijter, E.; Orru, R. V. A. Chem. Eur. J. 2011, 17, 15039 (d) Vlaar, T.; Ruijter, E.; Znabet, A.; Janssen, E.; De Kanter, F. J. J.; Maes, B. U. W.; Orru, R. V. A. Org. Lett. 2011, 13, 6496 (e) Soeta, T.; Tamura, K.; Ukaji, Y. Org. Lett. 2012, 14, 1226 (f) Liu, B.; Li, Y.; Jiang, H.; Yin, M.; Huang, H. Adv. Synth. Catal. 2012, 354, 2288 (g) MacMillan, S. N.; Tanskia, J. M.; Waterman, R. Chem. Commun., 2007, 4172 (h) Qiu, G.; He, Y.; Wu, J. Chem. Commun. 2012, 48, 3836 (i) Masdeu, C.; Gómez, E.;. Williams, N. A. O.; Lavilla, R. Angew. Chem. Int. Ed. 2007, 46, 3043.

Fei, X-D.; Ge, Z-Y.; Tang, T.; Zhu, Y-M.; Ji, S-J. J. Org. Chem., 2013, 78, 3170-5.

Tyagi, V.; Khan, S.; Giri, A.; Gauniyal, H. M.; Sridhar, B.; Chauhan, P. M. S. Org. Lett. 2012, 14, 3126.

Tyagi, V; Khan, S; Chauhan, P.M. S, Synlett, 2013, 24, 0645–0651.

Typing the name of these drug and drug candidates into PubChem provides the compound structure, bioactivity, full list of literature, and access to ongoing clinical trials, applications, and usage: betrixaban (CID 10275777) and tariquidar (CID 148201).

Giri, R.; Lam, J. K.; Yu, J.-Q. J. Am. Chem. Soc. 2010, 132, 686.

Typing the name of these drugs into PubChem provides the compound structure, bioactivity, and access to ongoing clinical trials and applications: Tarceva (CID 176870) and Iressa (CID 123631).

Mhaske, S. B.; Argade, N. P. Tetrahedron 2006, 62, 9787–9826.

Joseph P. M. Nat. Prod. Rep. 2003, 20, 476–493.

(a) Bandekar, P. P.; Roopnarine, K. A.; Parekh, V. J.; Mitchell, T. R.; Novak, M. J.; Sinden, R. R. J. Med. Chem. 2010, 53, 3558–3565. (b) Bhattacharjee, A. K.; Skanchy, D. J.; Jennings, B.; Hudson, T. H.; Brendle, J. J.; Werbovetz, K. A. Bioorg. Med. Chem. 2002, 10, 1979–1989.

(a) Chen, A. L.; Chen, K. K. J. Am. Pharm. Assoc. 1933, 22, 716. (b) Chiou, W.; Liao, J.; Chen, C. J. Nat. Prod. 1996, 59, 374-378.

Liang, J. L.; Cha, H. C.; Jahng, Y. Molecules 2011, 16, 4861-4883.

(a) Chinigo, G. M.; Paige, M.; Grindrod, S.; Hamel, E.; Dakshanamurthy, S.; Chruszcz, M.; Minor, W.; and Milton L. Brown J. Med. Chem. 2008, 51, 4620–4631 (b) El-Azab, A. S.; ElTahir, K. E. H. Bioorg. Med. Chem. Lett. 2012, 22, 1879–1885. (c) Saravanan, G.; Alagarsamy, V.; Prakash, C. R. Bioorg. Med. Chem. Lett. 2012, 22, 3072–3078.

Wang, Z.; Wang, M.; Yao, X.; Li, Y.; Tan, J.; Wang, L.; Qiao, W.; Geng, Y.; Liu, Y.; Wang, Q. Eur. J. Med. Chem. 2012, 53, 275-282.

(a) Abbas, S.; E.; Awadallah, F.; M.; Ibrahin, N.; A.; Said, E.; G.; Kamel, G.; M. Eur. J. Med. Chem. 2012, 53, 141-149 (b) Amin, K. M.; Kamel, M. M.; Anwar, M. M.; Khedr, M.; Syam, Y. M. Eur. J. Med. Chem. 2010, 45, 2117–2131.

(a) Al-Omary, F. A. M.; Abou-zeid, L. A.; Nagi, M. N.; Habib, E. E.; Abdel-Aziz, A. M.; El-Azab, A. S.; Abdel-Hamide, S. G.; Al-Omar, M. A.; Al-Obaid, A. M.; El-Subbagh, H. I. Bioorg. Med. Chem. Lett. 2010, 18, 2849–2863 (b) Suresha, G.; P.; Suhas, R.; Kapfo, W.; Gowda, D. C. Eur. J. Med. Chem. 2011, 46, 2530-2540.

Mohameda, M.; S.; Kamel, M.; M.; Kassem, E.; M.; M.; Abotaleb, N.; Abd El-moez, S.; I.; Ahmeda, M.; F. Eur. J. Med. Chem. 2010, 45, 3311-3319.

Rudolph, J.; Esler, W.; P.; O’Connor, S.; Coish, P.; D.; G.; Wickens, P.; L.; Brands, M.; Bierer, D.; E.; Bloomquist, B.; T.; Bondar, G.; Chen, L.; Chuang, C.; Claus, T.; H.; Fathi, Z.; Fu, W.; Khire, U.; R.; Kristie, J.; A.; Liu, X.; Lowe, D.; B.; McClure, A.; C.; Michels, M.; Ortiz, A.; A.; Ramsden, P.; D.; Schoenleber, R.; W.; Shelekhin, T.; E.; Vakalopoulos, A.; Wang, L.; Yi, L.; Gardell, S.; J.; Livingston, J.; N.; Sweet, L.; J.; Bullock, W.; H. J. Med. Chem. 2007, 50, 5202-5216.

Rhee, H.; Yoo, J.; H.; Lee, E.; Kwon, Y.; J.; Seo, H.; Lee, Y.; Choo, H.; P. Eur. J. Med. Chem. 2011, 46, 3900-3908.

Ismail, M.; A.; H.; Barker, S.; Abou El Ella, D.; A.; Abouzid, K.; A.; M.; Toubar, R.; A.; Todd, M.; H. J. Med. Chem. 2006, 49, 1526-1535.

Sharma, M.; Pandey, S.; Chauhan, K.; Sharma, D.; Kumar, B.; Chauhan, P. M. S. J. Org. Chem. 2012, 77, 929.

Goldstein, J. L.; Brown, M. S. Nature 1990, 343, 425.

For selected reviews on palladium-catalyzed aminocarbonylation, see: (a) Schoenberg, A.; Heck, R. F. J. Org. Chem. 1974, 39, 3327. (b) Cao, H.; McNamee, L.; Alper, H. Org. Lett. 2008, 10, 5281. (c) Brennfuhrer, A.; Neumann, H.; Beller, M. Angew. Chem., Int. Ed. 2009, 48, 4114. (d) Martinelli, J. R.; Clark, T. P.; Watson, D. A.; Munday, R. H.; Buchwald, S. L. Angew. Chem., Int. Ed. 2007, 46, 8460. (e) Orito, K.; Miyazawa, M.; Nakamura, T.; Horibata, A.; Ushito, H.; Nagasaki, H.; Yuguchi, M.; Yamashita, S.; Yamazaki, T.; Tokuda, M. J. Org. Chem. 2006, 71, 5951. (f) Salvadori, J.; Balducci, E.; Zaza, S.; Petricci, E.; Taddei, M. J. Org. Chem. 2010, 75, 1841. (g) Martinelli, J.R.;Freckmann, D. M. M.; Buchwald, S. L. Org. Lett. 2006, 8, 4843. (h) Barnard, C. F. J. Organometallics 2008, 27, 5402. (i) Kumar, K.; Zapf, A.; Michalik, D.; Tillack, A.; Heinrich, T.; B€ottcher, H.; Arlt,M.; Beller, M. Org. Lett. 2004,6, 7.

Mazurkiewicz, R Monatsh. Chem. 1989, 120, 973. (b) Snider, B.; Zeng, H. Heterocycles 2003, 61, 173. (c) Wang, H.; Ganesan, A. J. Org. Chem. 1998, 63, 2432.

(a) McKenney, J. M. Clin. Cardiol. (Suppl. III). 2003, 26, 32–38. (b) Speidal, K. M.; Hilleman, D. E. Expert Opin. Pharmacother. 2006, 7, 1291–1304.

(a) Shepard, J.; Cobbe, S. M.; Ford, I.; Isles, C. G.; Lorimer, A. R.; MacFarlane, P. W.; McKillop, J. H.; Pachard, C. J. N. Engl. J. Med. 1995, 333, 1301–1307. (b) LaRosa, J. C.; He, J.; Vupputuri, S. JAMA, J. Am. Med. Assoc. 1999, 282, 2340–2346.

Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S. and Olson, A. J. , J. Computational Chemistry 2009, 16: 2785-91

DeLano,W.L. (2002) The PyMol Molecular Graphics System DeLano Scientific, San Carlos, CA,USA.

Ntambi, J. M.; Young-Cheul, K. J. Nutr. 2000, 130, 3122S.

Cheung, K. J.; Tzameli, I.; Pissios, P.; Rovira, I.; Gavrilova, O.; Ohtsubo, T.; Chen, Z.; Finkel, T.; Flier, J. S.; Friedman, J. M. Cell Metab. 2007, 5, 115.

Christianson, J. L.; Nicoloro, S.; Straubhaar, J.; Czech, M. P. J. Biol. Chem. 2008, 283, 2906.

Published

26-04-2022

How to Cite

Lawaniya, Y. K., & Goyal, P. K. (2022). Synthesis of Novel Quinazolin-4-one hybrids as potential antimicrobial agents. International Journal of Health Sciences, 6(S2), 6042–6054. https://doi.org/10.53730/ijhs.v6nS2.6573

Issue

Section

Peer Review Articles